Creo Ingredients

Creo is a private biotechnology ingredient company focused on producing rare and novel cannabinoids through fermentation rather than plant extraction. The company developed a proprietary platform to manufacture cannabinoid ingredients such as cannabigerol and cannabigerolic acid at commercial scale, targeting health, wellness, beauty, and other consumer product applications. Creo partnered closely with Genomatica on technology development and scale-up, and highlighted sustainable production, product consistency, and contaminant-free supply as key differentiators. Public materials indicate the company launched commercially in 2020 and achieved demo- and commercial-scale fermentation milestones in 2021. However, more recent private-company databases list Creo as out of business as of 2025, despite the website remaining online.